Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
NEXTA BIOTECH CONSULTING AS
AS
Active
Org 934427076
Solveien 9, 1482
Nittedal
All other professional, scientific and technical activities n.e.c.
· NACE 7499
Est. 2024
— employees
Watchlist
Share
Norway
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
NEXTA BIOTECH CONSULTING AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
NOK thousands
Item
2024
Revenue
778
Staff expenses
−437
EBITDA
290
Depreciation & amort.
−0
EBIT
290
Net financials
0
Profit before tax
290
Tax
64
Net profit
227
Balance sheet
NOK thousands
Item
2024
Total assets
815
Equity
26
Long-term debt
0
Short-term debt
789
Total debt
789
Financial ratios
5-year trend
EBITDA-margin
37.3%
This company
15.8%
Market median
+136% vs market
2024
2024
Soliditetsgrad
3.2%
This company
38.2%
Market median
-92% vs market
2024
2024
Egenkapitalforrentning
879.3%
This company
18.4%
Market median
+4679% vs market
2024
2024
Nettoresultatgrad
29.1%
This company
8.1%
Market median
+259% vs market
2024
2024
Aktivomsætning
0.95×
This company
1.12×
Market median
+15% vs market
2024
2024
Gæld/egenkapital
30.62×
This company
0.62×
Market median
-4839% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
More on NEXTA BIOTECH CONSULTING AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
